Arsenic Biotransformation as a Cancer Promoting Factor by Inducing DNA Damage and Disruption of Repair Mechanisms by Martinez, Victor D. et al.
SAGE-Hindawi Access to Research
Molecular Biology International
Volume 2011, Article ID 718974, 11 pages
doi:10.4061/2011/718974
Review Article
Arsenic Biotransformation as a Cancer Promoting Factor by
InducingDNA Damage andDisruptionof RepairMechanisms
Victor D. Martinez,1,2 Emily A.Vucic,1 Marta Adonis,2 LionelGil,2 andWanL. Lam1
1Department of Integrative Oncology, BC Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC, Canada V5Z 1L3
2Biomedical Sciences Institute, Faculty of Medicine, University of Chile, Independencia 1027, 8380453 Santiago, Chile
Correspondence should be addressed to Victor D. Martinez, vmartinez@bccrc.ca
Received 16 March 2011; Accepted 6 June 2011
Academic Editor: Fr´ ed´ eric Coin
Copyright © 2011 Victor D. Martinez et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Chronic exposure to arsenic in drinking water poses a major global health concern. Populations exposed to high concentrations
of arsenic-contaminated drinking water suﬀer serious health consequences, including alarming cancer incidence and death rates.
Arsenicisbiotransformedthroughsequentialadditionofmethylgroups,acquiredfroms-adenosylmethionine(SAM).Metabolism
of arsenic generates a variety of genotoxic and cytotoxic species, damaging DNA directly and indirectly, through the generation of
reactive oxidative species and induction of DNA adducts, strand breaks and cross links, and inhibition of the DNA repair process
itself. Since SAM is the methyl group donor used by DNA methyltransferases to maintain normal epigenetic patterns in all human
cells, arsenic is also postulated to aﬀect maintenance of normal DNA methylation patterns, chromatin structure, and genomic
stability. The biological processes underlying the cancer promoting factors of arsenic metabolism, related to DNA damage and
repair, will be discussed here.
1.Introduction
Arsenic is one of the most abundant elements in the
Earth’s crust [1]. Chemically, it is classiﬁed as metalloid,
exhibiting organic (when linked with carbon and hydrogen)
and inorganic (combined with oxygen, chlorine, and sulfur,
among other elements) forms [2]. Inorganic arsenic (iAs)
canbepresentnaturallyinsoil,especiallyinrockscontaining
copperorlead,andintheatmosphereasairbornedust.Addi-
tionally, anthropogenic activities, such smelter operations,
can cause water contamination [3, 4]. In the environment,
iAs can be found in several oxidation states, more frequently
astrivalent(iAs[III],alsoknownasarsenite)andpentavalent
(iAs[V] or arsenate) species [5] .T h e s ef o r m sa r ed i ﬀerently
metabolized by mammals (see below) and exhibit distinct
grades of toxicity.
Several health eﬀects have been documented as a con-
sequence of iAs exposition, with the majority of harmful
exposure coming from ingestion through drinking water.
iAs-associated malignancies include skin lesions, hyperten-
sion, ischemia, some endemic peripheral vascular disorders
(e.g., “black foot disease”), severe arteriosclerosis, neu-
ropathies, noticeably, many types of cancer [6–9]. A number
of studies have established signiﬁcant associations and/or
dose response trends between iAs in drinking water and
occurrence of tumors of the skin, bladder, kidney, liver,
prostate, and lungs [10–15].
The evidence of a relationship between iAs in drinking
water and cancer is extensive and suﬃcient, leading to
the International Agency of Research on Cancer (IARC)
to consider this metalloid as a Group 1 human carcino-
gen. The estimated cancer-death risk associated with daily
consumption of 1.6 liters of water with iAs concentrations
of 50μg/L is 21/1,000 [16]. For these reasons, the World
Health Organization and the U.S. Environmental Protection
Agency have recommended a threshold of 10μg/L for iAs
concentration in drinking water [17, 18].
Despite eﬀorts to reduce high-scale exposure, many
nations throughout the world have iAs concentrations in
water that are above the recommended level [19–21].
Approximately 40 million people worldwide are thought to
be exposed to iAs levels that can be considered dangerous2 Molecular Biology International
[19]. Among them, 21 million people in Bangladesh and
India (West Bengal) are exposed to drinking water with iAs
concentrations >50μg/L [22], and shockingly, iAs concen-
tration in water wells in these areas has been documented
as high as 1000μg/L [23]. In China, it has been estimated
that more than 3 million people are exposed to iAs from
groundwater [24], while in southwestern Taiwan, some
residents have used well water contaminated with iAs for
more than 50 years (some ingesting as much as 1000μg
iAs/day) [25–27]. In Northern Chile, the population was
exposed to levels of iAs in drinking water around 900μg/L
between 1958 and 1970, with nearby towns registering
exposures of 600μg/mL as late as 1994 [11].
2. Arsenic Biotransformation
About 80–90% of ingested As[III] or As[V] is absorbed
from the gastrointestinal tract [28–30]. Data derived from
autopsies has determined that muscles, bones, kidneys,
and lungs have the highest absolute accumulated amounts
of iAs, while skin and excretory/storage organs, such as
nails and hair, are the most concentrated [31]. iAs[III]
exhibits a signiﬁcantly higher biological activity than As[V];
however, eﬀects observed in mammals could be similar,
since absorbed As[V] is mostly reduced to As[III] on the
initial steps of arsenic metabolism in mammals [32, 33].
Interestingly, there is evidence for interindividual diﬀerences
in iAs metabolism/excretion in humans and other species
[34, 35].
The biotransformation process of iAs occurs via methy-
lation through alternating reduction of As[V] to As[III], and
subsequentadditionofmethylgroups[36].Thismethylation
processusesS-adenosylmethionine(SAM)asamethylgroup
donor,throughaSAM-dependantAs[III]-methyltransferase,
initially isolated from rat liver and a human homologue of
cytochrome19 [37]. This enzyme catalyzes the transfer of a
methyl group from SAM to As[III] producing methylated
and dimethylated arsenic compounds. Trivalent methylated
species, such monomethylarsonous acid (MMA[III]) and
dimethylarsinic acid (DMA[III]), have been detected in the
urine of patients chronically exposed to iAs in drinking
water [38, 39]. Methylated pentavalent arsenicals such as
monomethylarsonic acid (MMA[V]) and dimethylarsinic
acid(DMA[V])aremajormetabolitesofiAsinhumanurine,
with DMA[V] being the ﬁnal metabolite in humans [39–
41]. Derivate methylated species from iAs metabolisms are
considered relevant agents during arsenic carcinogenicity,
specially through induction of oxidative stress and impairing
DNA repair processes. These aspects will be discussed in the
following sections.
Despite evidence of biotransformation role in arsenic
carcinogenicity, it has been demonstrated that arsenic can
induce malignant transformation in cell lines with deﬁcient
arsenic-methylation capacity. Arsenic methylation-deﬁcient
RWPE-1 human prostate cells undergo malignant transfor-
mation when exposed to 5.0μM of iAs[III] during 30 weeks
[42]. Alternative mechanism of arsenic-induced malignant
transformation might be associated with mitochondrial
dysfunction (see below), speciﬁcally through transcription
and replication of the mitochondrial genome, in which the
mitochondrial transcription factor A (mtTFA) and its reg-
ulators, such the nuclear respiratory factor-1 (NRF-1), play
key roles [43, 44]. In this context, it has been demonstrated
that mtTFA and NRF-1 expressions levels are increased
in cells exposed to iAs[III] in a concentration-dependent
manner, suggesting that arsenic regulates mitochondrial
activity through an NRF-1-dependent pathway [45].
3. ArsenicCarcinogenicity:Role of
Oxidative Stress
Despite the strong relationship between iAs exposure and
cancer, the exact mechanism is still unknown. There is
evidence supporting low level mutagenic activity of iAs;
however, it has also been shown that iAs can induce
transformation in several cell types [46, 47]. Moreover, iAs
caninterferewithanumberofbiologicalprocesses,including
DNA methylation, since the arsenic biotransformation path-
wayusesSAMasamethylgroupdonor.Therefore,epigenetic
mechanisms have also been proposed to participate in iAs-
induced carcinogenesis [48].
Biotransformation of iAs has been proposed to generate
ﬁnal and intermediate metabolites exhibiting higher toxicity
and reactivity compared to originally ingested iAs [5, 49,
50]. Methylated species, especially DMA[V], have been
demonstrated to be genotoxic and cytotoxic [46, 49, 51–
53]. Several studies have shown that DMA[V] can exhibit
carcinogenic potential in mammals, mainly in lungs, skin,
liver, kidney, thyroid, and urinary bladder [39, 54–58]. It has
been proposed that DMA[V] can participate in promoting
tumorigenesis of lungs and skin in mouse via the production
of dimethylated arsenic peroxide [(CH3)2AsOO·], a type
of reactive oxygen species (ROS) generated during iAs
metabolism [53, 54].
In the light of these facts, oxidative stress has been
proposed as a plausible general mode of action for iAs
carcinogenesis [59–63]. Oxidative stress is characterized by
generation of several ROS, such as superoxide anion (O2
−),
hydroxyl radical (·OH), hydrogen peroxide (H2O2), singlet
oxygen(1O2),andperoxylradical(LOO),amongothers[64].
One of the primary species formed in iAs-induced oxidative
stress is O2
−, followed by a cascade of secondary ROS such as
H2O2 and ·OH [61].
iAs exposure results in the generation of ROS in various
cellular systems, and its production has been proposed as
one of the early biological events on iAs-related carcinogenic
process [65]. In addition, cultured vascular endothelial cells
exposed to iAs increase oxygen cell consumption contribut-
ing to increased ROS production, stimulating cell signaling
and activating transcription factors [66]. Conversely, ROS
scavengers can suppress arsenic-induced oxidative stress and
itscytotoxiceﬀectsincells[67,68].Ithasalsobeendescribed
that iAs exposure can aﬀect expression of genes associated
with stress-related components, DNA damage and repair-
responsive genes, activation of transcription factors such
as the AP-1 complex, and increases in proinﬂammatoryMolecular Biology International 3
cytokines, which could inﬂuence response to acute arsenic
toxicity [69]. Alternatively, ROS generation by iAs can
involve hepatic and renal heme oxygenase isoform 1, gen-
erating among others species, free iron which subsequently
participates in reactions where H2O2 is reduced to OH
− and
·OH [69]. Additionally, the oxidation of iAs[III] to As[V]
during formation of intermediary arsine species can also
generate H2O2 [70].
Mechanisms of iAs carcinogenicity could vary between
diﬀerent tissues, due to diﬀerent oxygen concentrations, and
accumulation of iAs species, endogenous reducing agents,
and ferritin, among others factors [71, 72]. For example,
lungs are exposed to the highest oxygen tensions in the body,
andDMA[III],anditsderivates(includingROS)areexcreted
through the lung, which could explain why this organ is
frequently aﬀected by iAs-induced carcinogens [60].
It has been suggested that arsenic-associated mitochon-
drial dysfunction, mitochondrial DNA (mtDNA) depletion,
and induction of mtDNA deletions may contribute to the
carcinogenicity in humans [73]. Also, mitochondria might
be an important target of arsenic-induced genotoxicity
[74]. On the other hand, since mitochondria is a major
source of intracellular ROS, arsenic-mediated disruption of
its function can lead to an increase in intracellular ROS
levels and subsequently, to an increased mutagenic potential,
either directly or by decreasing DNA repair capacity [73].
Relationships between mitochondria and arsenic-mediated
eﬀects are supported by observations such as suppression of
arsenic-induced apoptosis in HeLa cells by the antioxidant
action of N-acetyl-cysteine, which prevents mitochondrial
membrane depolarization [75]. Alternatively, arsenic can
act directly through condensing mitochondrial matrix and
opening of permeability transition pores [76].
4. DNA andChromosomal Damage by
iAS-InducedOxidativeStress
Genotoxicmechanismsassociatedwitharseniccarcinogenic-
ity remain controversial. While some groups argue against
this type of interaction, others have postulated this can be
a signiﬁcant mode of action. Rossman [46]h a sp r o p o s e d
that arsenite does not react directly with DNA. In the
same way, toxic doses (10–15μM) of iAs[III] act as a poor
mutagen at the gpt mutagenic target in transgenic Chinese
hamster G12 cells [77]. On the other hand, it has been
proposed that iAs[III] is a signiﬁcant mutagen that induces
mainly large chromosomal mutations [78]. Alternatively,
arsenic has been shown to be mutagenic to mitochondrial
DNA and can potentially induce nuclear DNA damage by
activating mitochondrial ROS through increased expression
of mtTFA [45]. Also, arsenic can induce mutations as well
as methylation changes in the mouse testicular Leydig cell
genome [79]. Similarly, comet assay performed on human
prostate epithelial cells exposed to 100pg/mL of arsenic
exhibited tail-like structures, suggesting induction of nuclear
DNA damage [45].
iAs is known to damage chromosomes [80]. Due to
little evidence of covalent binding between iAs and DNA
structures, it has been proposed that much of the DNA
damage observed during iAs exposure is indirect, occurring
mainly as a result of ROS induction which generates DNA
adducts, DNA strand breaks, cross links, and chromosomal
aberrations[81,82].Figure2indicatesthesequenceofevents
related to ROS induced DNA damage after iAs exposure.
Depending on which cell cycle phase exposure occurs, as
a consequence DNA oxidation, iAs can result in gross
chromosomal aberrations including DNA strand breaks [61,
69].
5.DNA StrandBreaks
iAs can induce DNA strand breaks even at low concen-
trations. Main related-events are summarized in Figure 1.
Single-strand DNA (ssDNA) breaks are the most common
lesions induced by exogenous genotoxins [83]. Arsenic-
induced ssDNA breaks are likely caused through ROS, either
directly by free-radical attack on the DNA bases or indirectly
during the course of base excision repair (BER) mechanisms
[84]. Arsenic-induced ROS has been shown to promote
ssDNA breaks in mice lungs [70]. Furthermore, human
ﬁbroblast cell lines exposed to iAs exhibit ssDNA breaks and
DNA-protein adducts, as well as sister chromatid exchanges
[85].
iAs is also capable of producing double-strand DNA
(dsDNA) breaks at concentrations of 5μM in mammalian
cells [86]. These are one of the most deleterious and
mutagenic DNA lesions experienced in human cells, leading
to gross losses of genetic material [87]. Therefore, iAs is
also proposed to act as a cocarcinogen, exacerbating damage
inducedbyotheragents.Inthiscontext,1μMofiAsincreases
UVR-mediated DNA strand breaks by interfering with
Poly-adenosine diphosphate-ribose polymerase 1 (PAPR-1)
activity, which plays an important role in the ssDNA or
dsDNA breaks repair process [88].
MMA[III] was found to be a potent clastogen in late
G1- or S-phase-treated cells; however, lesions induced by
MMA[III] are quickly repaired through BER mechanisms
when they are induced in G0- or G1-phase of the cell cycle
[84]. Trivalent arsenicals might induce either chromatid-
or chromosome-type aberrations during treatment in G0
or G1. If ssDNA or dsDNA breaks produced by iAs-
induced ROS pass the S-Phase (DNA synthesis), replication
occurs and chromatid- and chromosome-type aberrations
can be produced [89]. Evidence pertaining to these type of
aberrations is discussed below.
6. Arsenic-InducedChromatid and
Chromosomal Aberrations
Arsenic is a known inducer of chromosomal and chromatid
aberrations. Lee et al. [90] demonstrated that iAs can
eﬀectively induce methotrexate-resistance in mouse 3T6
cells, resulting in selection of cells with ampliﬁcation of
the dihydrofolate reductase gene [91]. Genetic changes were
observed in bladder tumor (transitional cell carcinoma,
TCC) from 123 patients in Argentina and Chile, exposed to4 Molecular Biology International
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Figure 1:Arsenic-inducedDNAstrandbreaks.Afteringestion,iAsbiotransformationprocesscouldleadtoiAsexcretion,mainlyconjugated
with Glutathione (GSH). On the other hand, biotransformation process may generate reactive oxygen species (ROS), probably in a speciﬁc
sequence: superoxide anions (O2
−), hydrogen peroxide (H2O2), and hydroxyl radicals (·OH). These species can induce both single-strand
(ssDNA) and double-strand (dsDNA) breaks by inducing oxidative damage. In parallel, they can inhibit DNA break repair mechanisms both
forssDNAbreaks(mainlybaseexcisionrepair[BER])andfordsDNAbreaks(homologousrecombination[HR]and/ornonhomologousend
joining [NHEJ]). Additionally, ROS derived from iAs biotransformation can act as cocarcinogens, for example, increasing damage potential
of ultraviolet (UV) light. All these events could be associated, in part, to iAs-related carcinogenic mechanism.
iAs exposure
Superoxide anions
Hydrogen peroxide
Hydroxyl radicals
Genotoxicity
Figure 2: Events related with ROS-induced DNA damage after iAs
exposure. Speciﬁc sequence of reactive oxygen species generation as
a consequence of iAs biotransformation in mammals.
iAs concentrations exceeding 500μg/L. Individuals exposed
to high As concentrations (>300–600μg/L) exhibited a
higher total number of chromosomal aberrations, support-
ing the hypothesis that exposure to iAs increases genomic
instability. Furthermore, chromosomal aberrations (specif-
ically DNA copy-number alterations) were more abundant
among iAs-exposed bladder TCC tumors from southwest
Taiwan compared with nonexposed tumors from the same
area [92]. Some alterations were common to those found
in other studies, suggesting that nonrandom events are
associated with As-induced urinary TCC formation and
progression [93].
Other large-scale cytogenetic aberrations have been
observed in iAs-exposed populations. Gonsebatt et al. [94]
analyzed cytogenetic eﬀects in individuals exposed to dif-
ferent levels of As in drinking water. People exposed to
iAs at an average of 400μg/L showed a signiﬁcant increase
in frequency of chromatid and isochromatid deletion in
ﬁrst-metaphase lymphocytes and micronuclei in oral and
epithelial exfoliated cells compared to individuals with lower
exposures. Women and children from the northeast Andean
Region of Argentina exposed to 200μg/L of iAs in drinking
water displayed higher micronuclei frequency compared to
people exposed to very low iAs concentrations, but did not
have altered frequency of other aberrations, such as sister
chromatid exchange, speciﬁc translocations, or cell-cycle
progression [95].
7. OxidativeDamage
DNA modiﬁcations due to iAs-induced ROS can produce
oxidative damage, which can be measured through the
presence in urine of products of guanine oxidation in
position8(8-oxo-2 -deoxyguanosine(8-oxodG),8-hydroxy-
guanine[8-oxo-G],8-hydroxyguanosine[8-oxy-Guo]and8-
hydroxy-2 -deoxyguanosine [8-OHdG] [64]. After DMA[V]
administration in terminal bronchiolar Clara cells from
mice, markers for oxidative stress were detected, including
8-oxodG [96]. Additionally, it has been demonstrated that
the presence of 8-OHdG was associated with administrationMolecular Biology International 5
of DMA[V] in iAs-related human keratoses, squamous cell
carcinoma,basal cellepithelioma, and normal skin fromiAs-
intoxicated patients [97–99]. Also, iAs[III] can induce 8-
OHdG and promote genomic instability by damaging DNA
and inducing oncogene expression (including several factors
regulating cell cycle progression) human breast cancer MCF-
7 adenocarcinoma epithelial cells exposed to iAs[III] [100].
Oral administration of DMA[V] increases 8-oxo-G levels
through (CH3)2AsOO· [54, 55].
8. Inhibition of DNA Repair Mechanisms
AssociatedwithArsenicExposure
iAs can also induce DNA damage by interfering with the
DNA repair processes. Inhibition or impairment of the
DNA repair processes, principally the repair of DNA strand
breaks, is considered one of the main mechanisms of
iAs carcinogenesis [88, 101, 102]. For example, DMA[V]
aﬀects DNA repair and replication mechanisms in human
alveolar cells, leading to persistence DNA damage (mainly
apurinic/apyrimidinic sites) and generating ssDNA breaks as
a consequence [103, 104].
DNA base damage (induced by oxidative stress) can
be repaired through excision repair mechanisms, which are
subdivided into BER and nucleotide excision repair (NER)
pathways [105]. BER is the predominant repair pathway
for DNA lesions caused by ROS, and the ﬁrst candidate
in iAs-related DNA repair [69, 106]. Transcription levels of
genes related to BER mechanisms are altered in a gene, age-
, dose-, and duration-dependent manner in lung tissue of
mice exposed to iAs [107]. On the other hand, iAs was also
shown to alter BER mechanisms in GM847 lung ﬁbroblasts
and HaCaT keratinocytes, increasing levels of BER-related
enzymes and repair capacity [108].
SeveralenzymesparticipateintheBERmechanism,some
of which are known to be modulated by iAs. Among them,
DNA polymerase β (Polβ) and DNA ligase I (LIG1) have
been described as aﬀected by As[III] [109, 110]. Normally,
after generation of 5  incision on an abasic site leaving a 3 -
hydroxyl and a 5 -deoxyribose 5-phosphate, Polβ hydrolyses
the 5 -sugar phosphate and adds at least one nucleotide to
the 3 -hydroxyl end. The remaining strand is nick sealed
by LIG1, and PARP-1 may recruit the required proteins
[108]. However, in lung ﬁbroblasts and HaCaT keratinocytes
exposed to As[III], Pol β mRNA levels are downregulated
in a dose-dependent manner (doses >1μM), and at doses
lower than 1μM both Pol β mRNA and protein levels,
and consequently, BER activity, were signiﬁcantly increased
[108]. Additionally, this enzyme is stimulated in response
to low doses iAs and modulated by other sources of
oxidative stress [111–114]. Interestingly DNA copy-number
alterations (CNAs) in lung squamous cell carcinoma (SqCC)
from iAs-exposed patients from northern Chile contain the
Polδ 1 (DNA polymerase δ 1, catalytic subunit), which codes
for the proofreading domain of the DNA polymerase δ
complexandalsoparticipatesinssDNAbreaksrepairprocess
[115–119].
It has been proposed that iAs[III] works at transcrip-
tional level to repress a group of genes encoding for DNA
Chromosome 3
Figure 3: Comparison of CNA frequency at chromosome 3
between lung SqCC exposed and nonexposed to iAs. The ﬁgure
represents a comparison of CNA frequency at chromosome 3
generated from 52 lung SqCC biopsies by using a submegabase
resolution tiling-set rearray (SMRTr) platform. Of those, 22 derived
from arsenic-exposed smokers and never smokers patients from
Northern Chile (red) and 30 were current and ex-smokers North
American patients without known arsenic exposure nonexposed
(blue). Frequency of alteration results for exposed and nonexposed
SqCCs cases has been overlaid in this ﬁgure, with regions in yellow,
denoting a sector of overlapping alteration status in both groups.
The magnitude of red, yellow and blue bars represents percentage
of samples exhibiting corresponding alteration (0–100%, with blue
vertical lines representing 50% frequency). DNA gains and losses
are represented to the right and left of chromosome, respectively.
Adapted from Martinez et al. [115].
repair enzymes participating in BER and NER mechanisms,
mainly through its downregulation. This, in combination
with other events, contributes to toxicity or cancer [120]. In
parallel, changes in expression levels have been also corrob-
orated in human exposed populations. Exposure to arsenic
in drinking water was correlated to decreased expression
of ERCC1, XPB, and XPF in lymphocytes from exposed
individuals [121]. Decreased ERCC1 gene expression was
conﬁrmed in lymphocytes treated with > 1μM of iAs[III],
and a signiﬁcant reduction of ERCC1 protein levels was
observed among individuals exposed to drinking water
with low levels of arsenic [122]. Similarly, mRNA levels of
ERCC1 expression were signiﬁcantly associated with arsenic
concentrations in drinking water, implicating the DNA
repair response was induced by arsenic exposure [123]. On
the other hand, OGG1 expression (which encodes for 8-
oxoguanineDNAglycosylase,involvedinbaseexcisionrepair
of 8-oxoguanine [124]) was strongly associated with arsenic
concentrations [125], revealing involvement of mechanisms
related the eﬀects of arsenic-mediated ROS on DNA.
DNA ligation is a key step in DNA repair pathways [126].
Interestingly, it has been shown that iAs can speciﬁcally6 Molecular Biology International
inhibit this process as well. More recently we have found
that the mRNA, protein and activity levels of both DNA
ligase I and ligase III are signiﬁcantly reduced in mammalian
cellsinresponsetoAs[III][109].Additionally,As[III]retards
DNA break rejoining by interacting with the vicinal dithiols
and thus inhibiting DNA ligation [127]. Mammalian cells
have been shown to exhibit a dose-dependent decrease in
ligase activity with exposure to As[III], corresponding to
a decrease in mRNA levels of this enzyme [108, 128]. On
the other hand, it has been also shown that LIG1 and
other DNA damage/repair genes were increased by As[III]
and As[V] treatment, suggesting a cellular response to iAs-
induced DNA damage [129].
Members of the poly (ADP-ribose) polymerase (PARP)
family also play an important role in the regulation of DNA
damage repair. PARP-1 (accounting for about 90% of the
total cellular poly ADP-ribose formation) acts as a “DNA
damage sensor”, exhibiting high aﬃnity to bind both ssDNA
and dsDNA breaks [130–132]. It has been proposed that lack
of PARP-1 enhances cellular sensitivity to As[III] [133]. Cells
deﬁcient in this gene product display greater telomere attri-
tion. This process can be attributable to susceptibility of the
triple-G-containingstructuresoftelomericDNAtooxidative
damage [134, 135]. In parallel, cells deﬁcient in PARP-1
exhibit reduced repair of 8-oxoguanine, another marker for
oxidative damage that can potentially be induced by iAs
[136]. Finally, speciﬁc CNAs located at located at 10q11.23
in lung SqCC from iAs-exposed patients from northern
Chile contain the PARG (polyADP-ribose glycohydrolase)
gene, which also participates in ssDNA breaks repair process
[102, 115, 137].
9. GenomicLandscapeof Arsenic-Related
Lung Cancer
Lungs are the most frequently aﬀected organ by iAs, and
lung cancer remains the main cause of iAs-related death
[24]. Tobacco exposure is the main aetiological factor in lung
cancer; however, iAs ingestion through drinking water also
represents a risk factor, particularly for lung squamous cell
carcinomas (SqCCs). Interestingly, the incidence of SqCC is
decreasing worldwide and is usually associated with cigarette
smoking, but in Northern Chilean populations exposed
to arsenic contaminated drinking water, SqCC frequently
occurs in never smokers, [14, 138] suggesting distinct molec-
ular tumorigenic pathways may underlie arsenic-related can-
cers.
To this eﬀect, it was determined if globally, there existed
CNAs speciﬁc to lung SqCC cases from a Northern Chilean
population chronically exposed to iAs in drinking water
[115], using a whole genome tiling-path array compara-
tive genomic hybridization (CGH) platform [139]. It was
detected a surprisingly low frequency of DNA gains at
chromosome arm 3q in lung SqCCs from arsenic-exposed
individuals (Figure 3), which is remarkable, since DNA gains
at 3q are the most widely reported alteration associated with
lung SqCC tumors and cell lines [140, 141].
It was also identiﬁed speciﬁc DNA gains and losses
associated with lung SqCC from never smokers exposed
to iAs. For example, a speciﬁc and frequent DNA gain at
19q13.33 contains genes related to ssDNA breaks repair pro-
cess (POLD1) and neoplastic processes (SPIB and NR1H2).
Additionally, a widespread association of DNA copy number
loss speciﬁc to iAs-exposed lung SqCC, concordant with
previous ﬁndings showing that arsenic can induce multiple
large deletions through the creation of ROS [142]w a s
identiﬁed. Some of these deletions, mainly at 9q12, may be
relevant to iAs carcinogenic mechanisms, since they have
been described in other iAs-related types of cancer and
involvegenesfromtheforkheadbox(Fox)genefamily,which
have been linked to tumorigenesis and cancer progression
[143].
This recent information provides evidence of distinct
CNAs associated with lung SqCC occurring in patients who
had exposure to iAs in drinking water and suggests that
alternative molecular pathways are activated in this disease
subset.
10. Conclusion
Arsenic exposure through contaminated drinking water pos-
es a major health concern for over 40 million people world-
wide, where for some, arsenic levels are almost 10 times
higher than recommended thresholds. In addition to causing
a variety of health problems including vascular and neu-
rological conditions, arsenic is an established carcinogen.
The rate of cancer incidence and mortality in populations
exposed to arsenic contaminated drinking water is alarming.
These populations experience particularly exacerbated rates
of cancer in organs where arsenic is most concentrated or
is excreted, including lung, bladder, and skin cancers. The
mechanisms of arsenic-induced carcinogenesis are slowly
being elucidated through the study of the precise DNA
damaging and cytotoxic properties related to the biotrans-
formation, metabolism, and excretion of arsenic. Discovery
of particular genomic and epigenomic lesions induced by
this metalloid should encourage a comprehensive approach
to elucidate how arsenic can induce diﬀerent types of
cancer. Despite histology similarity, the possibility of iAs-
induced cases biologically distinct entities, compared to
those induced by other environmental carcinogens, must
be considered. Knowledge related to these processes may
leadtospeciﬁctreatmentstrategiestargetingarsenic-induced
disorders and malignancies.
Acknowledgments
This work was supported by funds from the Canadian
Institutes for Health Research (CIHR; MOP 86731, MOP
94867) and a CIHR CGS scholarship to E. A. Vucic. V. D.
Martinez was supported by INNOVA-Chile grant 07CN13-
PBT-48.Molecular Biology International 7
References
[1] C. Klein, Mineral Science, Wiley, New York, NY, USA, 2002.
[2] ATSDR,A.f.T.S.a.D.R.,ToxicologicalProﬁleforArsenic,P.H.S.,
U.S. Department of Health and Human Services, 2007.
[ 3 ]J .M .A z c u e ,A .M u d r o c h ,F .R o s a ,G .E .M .H a l l ,T .
A. Jackson, and T. Reynoldson, “Trace elements in water,
sediments, porewater, and biota polluted by tailings from an
abandoned gold mine in British Columbia, Canada,” Journal
of Geochemical Exploration, vol. 52, no. 1-2, pp. 25–34, 1995.
[4] P. L. Smedley and D. G. Kinniburgh, “A review of the source,
behaviour and distribution of arsenic in natural waters,”
Applied Geochemistry, vol. 17, no. 5, pp. 517–568, 2002.
[5] M. Vahter and G. Concha, “Role of metabolism in arsenic
toxicity,” Pharmacology and Toxicology, vol. 89, no. 1, pp. 1–
5, 2001.
[6] C. J. Chen, Y. M. Hsueh, M. S. Lai et al., “Increased
prevalence of hypertension and long-term arsenic exposure,”
Hypertension, vol. 25, no. 1, pp. 53–60, 1995.
[7] R. R. Engel, C. Hopenhayn-Rich, O. Receveur, and A.
H. Smith, “Vascular eﬀects of chronic arsenic exposure: a
review,” Epidemiologic Reviews, vol. 16, no. 2, pp. 184–209,
1994.
[8] T. Kadono, T. Inaoka, N. Murayama et al., “Skin man-
ifestations of arsenicosis in two villages in Bangladesh,”
InternationalJournalofDermatology, vol. 41, no. 12, pp. 841–
846, 2002.
[9] W. P. Tseng, H. M. Chu, S. W. How, J. M. Fong, C. S. Lin,
and S. Yeh, “Prevalence of skin cancer in an endemic area of
chronic arsenicism in Taiwan,” Journal of the National Cancer
Institute, vol. 40, no. 3, pp. 453–463, 1968.
[10] C. J. Chen and C. J. Wang, “Ecological correlation between
arsenic level in well water and age-adjusted mortality from
malignant neoplasms,” Cancer Research, vol. 50, no. 17, pp.
5470–5474, 1990.
[11] A. H. Smith, M. Goycolea, R. Haque, and M. L. Biggs,
“Marked increase in bladder and lung cancer mortality in a
region of northern chile due to arsenic in drinking water,”
American Journal of Epidemiology, vol. 147, no. 7, pp. 660–
669, 1998.
[12] C. Hopenhayn-Rich, M. L. Biggs, A. Fuchs et al., “Bladder
cancer mortality associated with arsenic in drinking water in
Argentina,” Epidemiology, vol. 7, no. 2, pp. 117–124, 1996.
[ 1 3 ] K .H .M o r a l e s ,L .R y a n ,T .L .K u o ,M .M .W u ,a n dC .J .C h e n ,
“Risk of internal cancers from arsenic in drinking water,”
Environmental Health Perspectives, vol. 108, no. 7, pp. 655–
661, 2000.
[14] C. Ferreccio, C. Gonz´ alez, V. Milosavjlevic, G. Marshall, A.
M. Sancha, and A. H. Smith, “Lung cancer and arsenic
concentrationsindrinkingwaterinChile,”Epidemiology,vol.
11, no. 6, pp. 673–679, 2000.
[15] G. Marshall, C. Ferreccio, Y. Yuan et al., “Fifty-year study of
lung and bladder cancer mortality in Chile related to arsenic
in drinking water,” Journal of the National Cancer Institute,
vol. 99, no. 12, pp. 920–928, 2007.
[16] A. H. Smith, C. Hopenhayn-Rich, M. N. Bates et al., “Cancer
risks from arsenic in drinking water,” Environmental Health
Perspectives, vol. 97, pp. 259–267, 1992.
[17] World health Organization (WHO), Guidelines for Drinking-
Water Quality, 1993.
[18] U. S. Environmental Protection Agency, Technical Fact Sheet:
Final Rule for Arsenic in Drinking Water, 2001.
[19] D. K. Nordstrom, “Worldwide occurrences of arsenic in
ground water,” Science, vol. 296, no. 5576, pp. 2143–2145,
2002.
[20] L. R. Croal, J. A. Gralnick, D. Malasarn, and D. K. Newman,
“The genetics of geochemistry,” Annual Review of Genetics,
vol. 38, pp. 175–202, 2004.
[21] A. Basu, J. Mahata, S. Gupta, and A. K. Giri, “Genetic
toxicology of a paradoxical human carcinogen, arsenic: A
review,” Mutation Research, vol. 488, no. 2, pp. 171–194,
2001.
[22] B. British Geological Survey, “British Geological Sur-
vey. Groundwater Studies for Arsenic Contamination in
Bangladesh,” Final Report, Mott MacDonald Ltd., 1999.
[23] R. Nickson, J. McArthur, W. Burgess, K. Matin Ahmed,
P. Ravenscroft, and M. Rahman, “Arsenic poisoning of
Bangladesh groundwater,” Nature, vol. 395, no. 6700, p. 338,
1998.
[24] M. N. Mead, “Arsenic: in search of an antidote to a global
poison,” Environmental Health Perspectives, vol. 113, no. 6,
pp. A378–A386, 2005.
[25] W. P. Tseng, “Eﬀects and dose response relationships of skin
cancer and blackfoot disease with arsenic,” Environmental
Health Perspectives, vol. 19, pp. 109–119, 1977.
[26] C.-J. Chen, M.-M. Wu, S.-S. Lee, J.-D. Wang, S.-H. Cheng,
and H.-Y. Wu, “Atherogenicity and carcinogenicity of high-
arsenic artesian well water. Multiple risk factors and related
malignant neoplasms of blackfoot disease,” Arteriosclerosis,
vol. 8, no. 5, pp. 452–460, 1988.
[27] R. Blackwell, “Estimation total arsenic ingested by residents
in Ihe endemic blackfoot area,” Journal of the Formosan
Medical Association, vol. 60, pp. 1143–1144, 1961.
[28] G. B. Freeman, R. A. Schoof, M. V. Ruby et al., “Bioavail-
ability of arsenic in soil and house dust impacted by smelter
activities following oral administration in cynomolgus mon-
keys,” Fundamental and Applied Toxicology,v o l .2 8 ,n o .2 ,p p .
215–222, 1995.
[ 2 9 ]C .P o m r o y ,S .M .C h a r b o n n e a u ,R .S .M c C u l l o u g h ,a n dG .
K. H. Tam, “Human retention studies with 74As,” Toxicology
and Applied Pharmacology, vol. 53, no. 3, pp. 550–556, 1980.
[30] M. Vahter and H. Norin, “Metabolism of 74As-labeled
trivalentandpentavalentinorganicarsenicinmice,”Environ-
mental Research, vol. 21, no. 2, pp. 446–457, 1980.
[31] World health Organization (WHO), Air Quality Guidelines,
W.R.Publications,WHORegionalOﬃceforEurope,Copen-
hagen, Denmark, 2nd edition, 2000.
[32] E. Marafante, M. Vahter, and J. Envall, “The role of the
methylation in the detoxication of arsenate in the rabbit,”
Chemico-Biological Interactions, vol. 56, no. 2-3, pp. 225–238,
1985.
[33] M. Vahter and E. Marafante, “Reduction and binding of
arsenate in marmoset monkeys,” Archives of Toxicology, vol.
57, no. 2, pp. 119–124, 1985.
[34] M. Vahter, “Methylation of inorganic arsenic in diﬀerent
mammalianspeciesandpopulationgroups,”ScienceProgress,
vol. 82, part 1, pp. 69–88, 1999.
[35] M. Vahter, “Genetic polymorphism in the biotransformation
ofinorganicarsenicanditsroleintoxicity,”Toxicology Letters,
vol. 112-113, pp. 209–217, 2000.
[36] D. J. Thompson, “A chemical hypothesis for arsenic methy-
lation in mammals,” Chemico-Biological Interactions, vol. 88,
no. 2-3, pp. 89–114, 1993.8 Molecular Biology International
[37] S. Lin, Q. Shi, F. Brent Nix et al., “A novel S-adenosyl-
L-methionine:arsenic(III) methyltransferase from rat liver
cytosol,” Journal of Biological Chemistry, vol. 277, no. 13, pp.
10795–10803, 2002.
[38] B. K. Mandal, Y. Ogra, and K. T. Suzuki, “Identiﬁcation of
dimethylarsinous and monomethylarsonous acids in human
urine of the arsenic-aﬀected areas in West Bengal, India,”
Chemical Research in Toxicology, vol. 14, no. 4, pp. 371–378,
2001.
[39] H. V. Aposhian, E. S. Gurzau, X. C. Le et al., “Occurrence
of monomethylarsonous acid in urine of humans exposed to
inorganic arsenic,” Chemical Research in Toxicology, vol. 13,
no. 8, pp. 693–697, 2000.
[40] M. M. Meza, M. J. Kopplin, J. L. Burgess, and A. J.
Gandolﬁ, “Arsenic drinking water exposure and urinary
excretion among adults in the Yaqui Valley, Sonora, Mexico,”
Environmental Research, vol. 96, no. 2, pp. 119–126, 2004.
[41] T. Hayakawa, Y. Kobayashi, X. Cui, and S. Hirano, “A new
metabolic pathway of arsenite: arsenic-glutathione com-
plexes are substrates for human arsenic methyltransferase
Cyt19,” Archives of Toxicology, vol. 79, no. 4, pp. 183–191,
2005.
[ 4 2 ]C .K o j i m a ,D .C .R a m i r e z ,E .J .T o k a re ta l . ,“ R e q u i r e m e n to f
arsenic biomethylation for oxidative DNA damage,” Journal
of the National Cancer Institute, vol. 101, no. 24, pp. 1670–
1681, 2009.
[43] M. I. Ekstrand, M. Falkenberg, A. Rantanen et al., “Mito-
chondrial transcription factor A regulates mtDNA copy
number in mammals,” Human Molecular Genetics, vol. 13,
no. 9, pp. 935–944, 2004.
[44] T. Kanki, K. Ohgaki, M. Gaspari et al., “Architectural role
of mitochondrial transcription factor a in maintenance of
human mitochondrial DNA,” Molecular and Cellular Biology,
vol. 24, no. 22, pp. 9823–9834, 2004.
[45] K. P. Singh, R. Kumari, J. Treas, and J. W. Dumond,
“Chronic exposure to arsenic causes increased cell survival,
DNA damage, and increased expression of mitochondrial
transcription factor A (mtTFA) in human prostate epithelial
cells,” ChemicalResearchinToxicology,vol.24,no.3,pp.340–
349, 2011.
[46] T. G. Rossman, “Mechanism of arsenic carcinogenesis: an
integrated approach,” Mutation Research, vol. 533, no. 1-2,
pp. 37–65, 2003.
[ 4 7 ] J .C .B a r r e t t ,P .W .L a m b ,T .C .W a n g ,a n dT .C .L e e ,“ M e c h a -
nismofarsenic-inducedcelltransformation,”BiologicalTrace
Element Research, vol. 21, pp. 421–429, 1989.
[48] P. P. Simeonova and M. I. Luster, “Mechanisms of arsenic
carcinogenicity: genetic or epigenetic mechanisms?” Journal
of Environmental Pathology, Toxicology and Oncology, vol. 19,
no. 3, pp. 281–286, 2000.
[ 4 9 ]M .S t y b l o ,L .M .D e lR a z o ,L .V e g ae ta l . ,“ C o m p a r a t i v et o x -
icity of trivalent and pentavalent inorganic and methylated
arsenicals in rat and human cells,” Archives of Toxicology, vol.
74, no. 6, pp. 289–299, 2000.
[50] J.S.Petrick,F.Ayala-Fierro,W.R.Cullen,D.E.Carter,andH.
Vasken Aposhian, “Monomethylarsonous acid (MMA(III))
is more toxic than arsenite in Chang human hepatocytes,”
Toxicology and Applied Pharmacology, vol. 163, no. 2, pp.
203–207, 2000.
[51] M. J. Mass, A. Tennant, B. C. Roop et al., “Methylated
trivalent arsenic species are genotoxic,” Chemical Research in
Toxicology, vol. 14, no. 4, pp. 355–361, 2001.
[52] S. Ahmad, K. T. Kitchin, and W. R. Cullen, “Arsenic species
that cause release of iron from ferritin and generation of
activated oxygen,” Archives of Biochemistry and Biophysics,
vol. 382, no. 2, pp. 195–202, 2000.
[53] K. Yamanaka, M. Mizoi, M. Tachikawa, A. Hasegawa, M.
Hoshino, and S. Okada, “Oxidative DNA damage following
exposure to dimethylarsinous iodide: the formation of cis-
thymine glycol,” Toxicology Letters, vol. 143, no. 2, pp. 145–
153, 2003.
[54] K. Yamanaka, M. Mizoi, K. Kato, A. Hasegawa, M. Nakano,
and S. Okada, “Oral administration of dimethylarsinic acid,
a main metabolite of inorganic arsenic, in mice promotes
skin tumorigenesis initiated by dimethylbenz(a)anthracene
with or without ultraviolet B as a promoter,” Biological and
Pharmaceutical Bulletin, vol. 24, no. 5, pp. 510–514, 2001.
[55] K. Yamanaka, K. Katsumata, K. Ikuma, A. Hasegawa, M.
Nakano, and S. Okada, “The role of orally administered
dimethylarsinicacid,amainmetaboliteofinorganicarsenics,
in the promotion and progression of UVB-induced skin
tumorigenesis in hairless mice,” Cancer Letters, vol. 152, no.
1, pp. 79–85, 2000.
[56] M. Wei, H. Wanibuchi, S. Yamamoto, W. Li, and S.
Fukushima, “Urinary bladder carcinogenicity of dimethy-
larsinic acid in male F344 rats,” Carcinogenesis, vol. 20, no.
9, pp. 1873–1876, 1999.
[57] H. Wanibuchi, S. Yamamoto, H. Chen et al., “Pro-
moting eﬀects of dimethylarsinic acid on N-butyl-N-(4-
hydroxybutyl)nitrosamine-induced urinary bladder carcino-
genesisinrats,”Carcinogenesis,vol.17,no.11,pp.2435–2439,
1996.
[58] S. Yamamoto, Y. Konishi, T. Matsuda et al., “Cancer induc-
tion by an organic arsenic compound, dimethylarsinic acid
(cacodylic acid), in F344/DuCrj rats after pretreatment with
ﬁve carcinogens,” Cancer Research, vol. 55, no. 6, pp. 1271–
1276, 1995.
[59] M. Kessel, S. X. Liu, A. Xu, R. Santella, and T. K. Hei,
“Arsenic induces oxidative DNA damage in mammalian
cells,” Molecular and Cellular Biochemistry, vol. 234-235, pp.
301–308, 2002.
[60] K. T. Kitchin and S. Ahmad, “Oxidative stress as a possible
modeofaction forarseniccarcinogenesis,” Toxicology Letters,
vol. 137, no. 1-2, pp. 3–13, 2003.
[61] H. Shi, X. Shi, and K. J. Liu, “Oxidative mechanism of
arsenic toxicity and carcinogenesis,” Molecular and Cellular
Biochemistry, vol. 255, no. 1-2, pp. 67–78, 2004.
[62] R. C. Lantz and A. M. Hays, “Role of oxidative stress in
arsenic-induced toxicity,” Drug Metabolism Reviews, vol. 38,
no. 4, pp. 791–804, 2006.
[63] M. Valko, C. J. Rhodes, J. Moncol, M. Izakovic, and M.
Mazur, “Free radicals, metals and antioxidants in oxidative
stress-induced cancer,” Chemico-Biological Interactions, vol.
160, no. 1, pp. 1–40, 2006.
[64] A. De Vizcaya-Ruiz, O. Barbier, R. Ruiz-Ramos, and M.
E. Cebrian, “Biomarkers of oxidative stress and damage in
human populations exposed to arsenic,” Mutation Research,
vol. 674, no. 1-2, pp. 85–92, 2009.
[65] K. T. Kitchin and R. Conolly, “Arsenic-induced carcinogen-
esissoxidative stress as a possible mode of action and future
research needs for more biologically based risk assessment,”
Chemical Research in Toxicology, vol. 23, no. 2, pp. 327–335,
2010.
[66] A. Barchowsky, L. R. Klei, E. J. Dudek, H. M. Swartz, and P.
E. James, “Stimulation of reactive oxygen, but not reactive
nitrogen species, in vascular endothelial cells exposed to lowMolecular Biology International 9
levels of arsenite,” Free Radical Biology and Medicine, vol. 27,
no. 11-12, pp. 1405–1412, 1999.
[67] F. Liu and K. Y. Jan, “DNA damage in arsenite- and
cadmium-treated bovine aortic en-do-the-lial cells,” Free
Radical Biology and Medicine, vol. 28, no. 1, pp. 55–63, 2000.
[68] S. J. S. Flora, “Arsenic-induced oxidative stress and its
reversibility following combined administration of N-
acetylcysteine and meso 2,3-dimercaptosuccinic acid in rats,”
Clinical and Experimental Pharmacology and Physiology, vol.
26, no. 11, pp. 865–869, 1999.
[69] S. X. Liu, M. Athar, I. Lippai, C. Waldren, and T. K.
Hei, “Induction of oxyradicals by arsenic: implication for
mechanism of genotoxicity,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 98,
no. 4, pp. 1643–1648, 2001.
[70] K. Yamanaka and S. Okada, “Induction of lung-speciﬁc DNA
damage by metabolically methylated arsenics via the produc-
tion of free radicals,” Environmental Health Perspectives, vol.
102, no. 3, pp. 37–40, 1994.
[71] E. M. Kenyon, M. F. Hughes, B. M. Adair et al., “Tissue
distribution and urinary excretion of inorganic arsenic and
its methylated metabolites in C57BL6 mice following sub-
chronic exposure to arsenate in drinking water,” Toxicology
andAppliedPharmacology,vol.232,no.3,pp.448–455,2008.
[72] S. Ahmad, K. T. Kitchin, and W. R. Cullen, “Plasmid DNA
damage caused by methylated arsenicals, ascorbic acid and
human liver ferritin,” Toxicology Letters, vol. 133, no. 1, pp.
47–57, 2002.
[73] M. A. Partridge, S. X. L. Huang, E. Hernandez-Rosa, M. M.
Davidson, and T. K. Hei, “Arsenic induced mitochondrial
DNA damage and altered mitochondrial oxidative function:
implications for genotoxic mechanisms in mammalian cells,”
Cancer Research, vol. 67, no. 11, pp. 5239–5247, 2007.
[74] S. X. Liu, M. M. Davidson, X. Tang et al., “Mitochondrial
damage mediates genotoxicity of arsenic in mammalian
cells,” Cancer Research, vol. 65, no. 8, pp. 3236–3242, 2005.
[75] S. H. Woo, I. C. Park, M. J. Park et al., “Arsenic triox-
ide induces apoptosis through a reactive oxygen species-
dependent pathway and loss of mitochondrial membrane
potential in HeLa cells,” International Journal of Oncology,
vol. 21, no. 1, pp. 57–63, 2002.
[76] S.J.Flora,“Arsenic-inducedoxidativestressanditsreversibil-
ity,” Free Radical Biology & Medicine, vol. 51, no. 2, pp. 257–
281, 2011.
[77] J. H. Li and T. G. Rossman, “Comutagenesis of sodium
arsenite with ultraviolet radiation in Chinese hamster V79
cells,” Biology of Metals, vol. 4, no. 4, pp. 197–200, 1991.
[78] T. K. Hei, S. U. X. Liu, and C. Waldren, “Mutagenicity of
arsenic in mammalian cells: role of reactive oxygen species,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 95, no. 14, pp. 8103–8107, 1998.
[79] K. P. Singh and J. W. DuMond, “Genetic and epigenetic
changes induced by chronic low dose exposure to arsenic
of mouse testicular Leydig cells,” International Journal of
Oncology, vol. 30, no. 1, pp. 253–260, 2007.
[80] A. D. Kligerman, C. L. Doerr, A. H. Tennant et al., “Methy-
lated trivalent arsenicals as candidate ultimate genotoxic
forms of arsenic: induction of chromosomal mutations but
not gene mutations,” Environmental and Molecular Mutagen-
esis, vol. 42, no. 3, pp. 192–205, 2003.
[81] K. T. Kitchin and K. Wallace, “Evidence against the nuclear
in situ binding of arsenicals-oxidative stress theory of arsenic
carcinogenesis,” Toxicology and Applied Pharmacology, vol.
232, no. 2, pp. 252–257, 2008.
[82] B. Halliwell, “Oxidative stress and cancer: have we moved
forward?”BiochemicalJournal,vol.401,no.1,pp.1–11,2007.
[83] K. W. Caldecott, “DNA single-strand breaks and neurode-
generation,” DNA Repair, vol. 3, no. 8-9, pp. 875–882, 2004.
[84] A.D.Kligerman,S.I.Malik,andJ.A.Campbell,“Cytogenetic
insights into DNA damage and repair of lesions induced by a
monomethylatedtrivalentarsenical.,”Mutation Research,vol.
695, no. 1-2, pp. 2–8, 2010.
[85] S. A. Mour´ on, C. A. Grillo, F. N. Dulout, and C. D. Golijow,
“Induction of DNA strand breaks, DNA-protein crosslinks
and sister chromatid exchanges by arsenite in a human lung
cellline,”ToxicologyinVitro,vol.20,no.3,pp.279–285,2006.
[ 8 6 ]S .Y i n g ,K .M y e r s ,S .B o t t o m l e y ,T .H e l l e d a y ,a n dH .E .
Bryant, “BRCA2-dependent homologous recombination is
required for repair of Arsenite-induced replication lesions in
mammalian cells,” Nucleic Acids Research, vol. 37, no. 15, pp.
5105–5113, 2009.
[ 8 7 ] T .H e l l e d a y ,J .L o ,D .C .v a nG e n t ,a n dB .P .E n g e l w a r d ,“ D N A
double-strand break repair: from mechanistic understanding
to cancer treatment,” DNA Repair, vol. 6, no. 7, pp. 923–935,
2007.
[88] X. J. Qin, L. G. Hudson, W. Liu, G. S. Timmins, and K. J. Liu,
“Low concentration of arsenite exacerbates UVR-induced
DNA strand breaks by inhibiting PARP-1 activity,” Toxicology
and Applied Pharmacology, vol. 232, no. 1, pp. 41–50, 2008.
[89] A. D. Kligerman and A. H. Tennant, “Insights into the
carcinogenic mode of action of arsenic,” Toxicology and
Applied Pharmacology, vol. 222, no. 3, pp. 281–288, 2007.
[90] T. C. Lee, N. Tanaka, P. W. Lamb, T. M. Gilmer, and J. C.
Barrett,“Inductionofgeneampliﬁcationbyarsenic,”Science,
vol. 241, no. 4861, pp. 79–81, 1988.
[91] F. W. Alt, R. E. Kellems, J. R. Bertino, and R. T. Schimke,
“Selective multiplication of dihydrofolate reductase genes
in methotrexate-resistant variants of cultured murine cells,”
Journal of Biological Chemistry, vol. 253, no. 5, pp. 1357–
1370, 1978.
[92] L. E. Moore, A. H. Smith, C. Eng et al., “Arsenic-related
chromosomal alterations in bladder cancer,” Journal of the
National Cancer Institute, vol. 94, no. 22, pp. 1688–1696,
2002.
[93] L. I. Hsu, A. W. Chiu, Y. S. Pu et al., “Comparative genomic
hybridization study of arsenic-exposed and non-arsenic-
exposed urinary transitional cell carcinoma,” Toxicology and
Applied Pharmacology, vol. 227, no. 2, pp. 229–238, 2008.
[94] M. E. Gonsebatt, L. Vega, A. M. Salazar et al., “Cytogenetic
eﬀectsinhumanexposuretoarsenic,”Mutation Research,vol.
386, no. 3, pp. 219–228, 1997.
[95] F. N. Dulout, C. A. Grillo, A. I. Seoane et al., “Chromosomal
aberrations in peripheral blood lymphocytes from native
Andean women and children from Northwestern Argentina
exposedtoarsenicindrinkingwater,”Mutation Research,vol.
370, no. 3-4, pp. 151–158, 1996.
[96] Y. An, K. Kato, M. Nakano, H. Otsu, S. Okada, and K.
Yamanaka, “Speciﬁc induction of oxidative stress in terminal
bronchiolar Clara cells during dimethylarsenic-induced lung
tumor promoting process in mice,” Cancer Letters, vol. 230,
no. 1, pp. 57–64, 2005.
[97] Y.An,Z.Gao,Z.Wangetal.,“Immunohistochemicalanalysis
of oxidative DNA damage in arsenic-related human skin10 Molecular Biology International
samples from arsenic-contaminated area of China,” Cancer
Letters, vol. 214, no. 1, pp. 11–18, 2004.
[98] M. Matsui, C. Nishigori, S. Toyokuni et al., “The role of
oxidative DNA damage in human arsenic carcinogenesis:
detection of 8-hydroxy-2 -deoxyguanosine in arsenic-related
Bowen’s disease,” Journal of Investigative Dermatology, vol.
113, no. 1, pp. 26–31, 1999.
[99] H. Wanibuchi, T. Hori, V. Meenakshi et al., “Promotion of
rat hepatocarcinogenesis by dimethylarsinic acid: association
with elevated ornithine decarboxylase activity and formation
of 8-hydroxydeoxyguanosine in the liver,” Japanese Journal of
Cancer Research, vol. 88, no. 12, pp. 1149–1154, 1997.
[100] R. Ruiz-Ramos, L. Lopez-Carrillo, A. D. Rios-Perez, A. De
Vizcaya-Ru´ ız, and M. E. Cebrian, “Sodium arsenite induces
ROS generation, DNA oxidative damage, HO-1 and c-Myc
proteins, NF-κB activation and cell proliferation in human
breast cancer MCF-7 cells,” Mutation Research, vol. 674, no.
1-2, pp. 109–115, 2009.
[101] A. Hartwig, H. Blessing, T. Schwerdtle, and I. Walter, “Mod-
ulation of DNA repair processes by arsenic and selenium
compounds,”Toxicology,vol.193,no.1-2,pp.161–167,2003.
[102] A.E.O.Fisher,H.Hochegger,S.Takeda,andK.W.Caldecott,
“Poly(ADP-ribose) polymerase 1 accelerates single-strand
break repair in concert with poly(ADP-ribose) glycohydro-
lase,” Molecular and Cellular Biology, vol. 27, no. 15, pp.
5597–5605, 2007.
[103] K. Yamanaka, H. Hayashi, K. Kalo, A. Hasegawa, and
S. Okada, “Involvement of pref-er-ential formation of
apurinic/apyrimidinicsitesindimethylarsenic-inducedDNA
strand breaks and DNA-protein crosslinks in cultured alve-
olar epithelial cells,” Biochemical and Biophysical Research
Communications, vol. 207, no. 1, pp. 244–249, 1995.
[104] K. Yamanaka, H. Hayashi, M. Tachikawa et al., “Metabolic
methylation is a possible genotoxicity-enhancing process of
inorganic arsenics,” Mutation Research, vol. 394, no. 1–3, pp.
95–101, 1997.
[105] J. de Boer and J. H. J. Hoeijmakers, “Nucleotide excision
repair and human syndromes,” Carcinogenesis, vol. 21, no. 3,
pp. 453–460, 2000.
[106] T. Schwerdtle, I. Walter, and A. Hartwig, “Arsenite and its
biomethylated metabolites interfere with the formation and
repair of stable BPDE-induced DNA adducts in human cells
and impair XPAzf and Fpg,” DNA Repair, vol. 2, no. 12, pp.
1449–1463, 2003.
[107] M.J.Osmond,B.A.Kunz,andE.T.Snow,“Ageandexposure
to arsenic alter base excision repair transcript levels in mice,”
Mutagenesis, vol. 25, no. 5, pp. 517–522, 2010.
[108] P. Sykora and E. T. Snow, “Modulation of DNA polymerase
beta-dependent base excision repair in cultured human cells
after low dose exposure to arsenite,” Toxicology and Applied
Pharmacology, vol. 228, no. 3, pp. 385–394, 2008.
[109] E. T. Snow, Y. Hu, C. B. Klein, K. L. McCluskey, M. Schuliga,
and P. Sykora, “Regulation of redox and DNA repair genes
by arsenic: low dose protection against oxidative stress?” in
Arsenic Exposure and Health Eﬀects V,W .R .C h a p p e l ,C .O .
Abernathy, R. L. Calderon, and D. J. Thomas, Eds., pp. 305–
319, Elsevier Science, San Diego, Calif, USA, 2003.
[110] E. T. Snow, Y. Hu, C. C. Yan, and S. Chouchane, “Modulation
of DNA repair and glutathione levels in human keratinocytes
by micromolar arsenite,” in Proceedings of the 3rd Interna-
tional Conference on Arsenic Exposure and Health Eﬀects,W .
R. Chappel, C. O. Abernathy, and R. L. Calderon, Eds., pp.
243–251, Elsevier Science, Oxford, UK, 1999.
[111] T. C. Zhang, M. T. Schmitt, and J. L. Mumford, “Eﬀects
of arsenic on telomerase and telomeres in relation to cell
proliferation and apoptosis in human keratinocytes and
leukemia cells in vitro,” Carcinogenesis, vol. 24, no. 11, pp.
1811–1817, 2003.
[112] D. C. Cabelof, J. J. Raﬀoul, S. Yanamadala, Z. Guo, and A.
R. Heydari, “Induction of DNA polymerase β-dependent
base excision repair in response to oxidative stress in vivo,”
Carcinogenesis, vol. 23, no. 9, pp. 1419–1425, 2002.
[113] K. H. Chen, D. K. Srivastava, R. K. Singhal, S. Jacob,
A. E. Ahmed, and S. H. Wilson, “Modulation of base
excision repair by low density lipoprotein, oxidized low
density lipoprotein and antioxidants in mouse monocytes,”
Carcinogenesis, vol. 21, no. 5, pp. 1017–1022, 2000.
[114] K. H. Chen, F. M. Yakes, D. K. Srivastava et al., “Up-
regulation of base excision repair correlates with enhanced
protection against a DNA damaging agent in mouse cell
lines,” Nucleic Acids Research, vol. 26, no. 8, pp. 2001–2007,
1998.
[115] V. D. Martinez, T. P. H. Buys, M. Adonis et al., “Arsenic-
related DNA copy-number alterations in lung squamous cell
carcinomas,” British Journal of Cancer, vol. 103, no. 8, pp.
1277–1283, 2010.
[116] C. Nishida, P. Reinhard, and S. Linn, “DNA repair synthesis
in human ﬁbroblasts requires DNA plymerase δ,” Journal of
Biological Chemistry, vol. 263, no. 1, pp. 501–510, 1988.
[117] J.L.Parsons,B.D.Preston,T.R.O’Connor,andG.L.Dianov,
“DNA polymerase δ-dependent repair of DNA single strand
breaks containing 3 -end proximal lesions,” Nucleic Acids
Research, vol. 35, no. 4, pp. 1054–1063, 2007.
[118] R. E. Goldsby, L. E. Hays, X. Chen et al., “High incidence
of epithelial cancers in mice deﬁcient for DNA polymerase
δ proofreading,” Proceedings of the National Academy of
Sciences of the United States of America, vol. 99, no. 24, pp.
15560–15565, 2002.
[119] R.N.Venkatesan,P.M.Treuting,E.D.Fulleretal.,“Mutation
at the polymerase active site of mouse DNA polymerase δ
increases genomic instability and accelerates tumorigenesis,”
MolecularandCellularBiology,vol.27,no.21,pp.7669–7682,
2007.
[120] H. K. Hamadeh, K. J. Trouba, R. P. Amin, C. A. Afshari,
and D. Germolec, “Coordination of altered DNA repair
and damage pathways in arsenite-exposed keratinocytes,”
Toxicological Sciences, vol. 69, no. 2, pp. 306–316, 2002.
[121] A. S. Andrew, M. R. Karagas, and J. W. Hamilton, “Decreased
DNA repair gene expression among individuals exposed to
arsenicinUnitedStatesdrinkingwater,”InternationalJournal
of Cancer, vol. 104, no. 3, pp. 263–268, 2003.
[122] A. S. Andrew, J. L. Burgess, M. M. Meza et al., “Arsenic
exposure is associated with decreased DNA repair in vitro
and in individuals exposed to drinking water arsenic,”
Environmental Health Perspectives, vol. 114, no. 8, pp. 1193–
1198, 2006.
[123] J. Mo, Y. Xia, Z. Ning, T. J. Wade, and J. L. Mumford,
“Elevated ERCC1 gene expression in blood cells associated
with exposure to arsenic from drinking water in inner
Mongolia,”Anticancer Research,vol.29,no.8,pp.3253–3259,
2009.
[124] A. Memisoglu and L. Samson, “Base excision repair in yeast
and mammals,” Mutation Research, vol. 451, no. 1-2, pp. 39–
51, 2000.
[125] J. Mo, Y. Xia, T. J. Wade et al., “Chronic arsenic exposure
and oxidative stress: OGG1 expression and arsenic exposure,Molecular Biology International 11
nail selenium, and skin hyperkeratosis in inner Mongolia,”
Environmental Health Perspectives, vol. 114, no. 6, pp. 835–
841, 2006.
[126] T. Lindahl and R. D. Wood, “Quality control by DNA repair,”
Science, vol. 286, no. 5446, pp. 1897–1905, 1999.
[127] S. Lynn, H. T. Lai, J. R. Gurr, and K. Y. Jan, “Arsenite
retards DNA break rejoining by inhibiting DNA ligation,”
Mutagenesis, vol. 12, no. 5, pp. 353–358, 1997.
[128] Y. Hu, L. Su, and E. T. Snow, “Arsenic toxicity is enzyme
speciﬁc and its aﬀects on ligation are not caused by the direct
inhibition of DNA repair enzymes,” Mutation Research, vol.
408, no. 3, pp. 203–218, 1998.
[129] J. Liu, M. B. Kadiiska, Y. Liu, T. Lu, W. Qu, and M. P.
Waalkes, “Stress-related gene expression in mice treated with
inorganic arsenicals,” Toxicological Sciences,v o l .6 1 ,n o .2 ,p p .
314–320, 2001.
[130] S. Shall and G. De Murcia, “Poly(ADP-ribose) polymerase-
1: what have we learned from the deﬁcient mouse model?”
Mutation Research, vol. 460, no. 1, pp. 1–15, 2000.
[131] A. B¨ urkle, J. Diefenbach, C. Brabeck, and S. Beneke, “Ageing
and PARP,” Pharmacological Research, vol. 52, no. 1, pp. 93–
99, 2005.
[132] V. Schreiber, F. Dantzer, J. C. Am´ e, and G. De Murcia,
“Poly(ADP-ribose): novel functions for an old molecule,”
Nature Reviews Molecular Cell Biology, vol. 7, no. 7, pp. 517–
528, 2006.
[133] A. Poonepalli, L. Balakrishnan, A. K. Khaw et al., “Lack
of poly(ADP-ribose) polymerase-1 gene product enhances
cellular sensitivity to arsenite,” Cancer Research, vol. 65, no.
23, pp. 10977–10983, 2005.
[134] F. Le Page, V. Schreiber, C. Dh´ erin, G. De Murcia, and
S. Boiteux, “Poly(ADP-ribose) polymerase-1 (PARP-1) is
required in murine cell lines for base excision repair of
oxidativeDNAdamageintheabsenceofDNApolymeraseβ,”
Journal of Biological Chemistry, vol. 278, no. 20, pp. 18471–
18477, 2003.
[135] S. Petersen, G. Saretzki, and T. von Zglinicki, “Preferential
accumulation of single-stranded regions in telomeres of
human ﬁbroblasts,” Experimental Cell Research, vol. 239, no.
1, pp. 152–160, 1998.
[136] F. Dantzer, G. De La Rubia, J. M´ enissier-De Murcia, Z.
Hostomsky, G. De Murcia, and V. Schreiber, “Base excision
repair is impaired in mammalian cells lacking poly(ADP-
ribose) polymerase-1,” Biochemistry, vol. 39, no. 25, pp.
7559–7569, 2000.
[137] H. Gao, D. L. Coyle, M. L. Meyer-Ficca et al., “Altered
poly(ADP-ribose) metabolism impairs cellular responses to
genotoxic stress in a hypomorphic mutant of poly(ADP-
ribose) glycohydrolase,” Experimental Cell Research, vol. 313,
no. 5, pp. 984–996, 2007.
[138] S. Sun, J. H. Schiller, and A. F. Gazdar, “Lung cancer in never
smokers—a diﬀerent disease,” Nature Reviews Cancer, vol. 7,
no. 10, pp. 778–790, 2007.
[139] S. K. Watson, R. J. deLeeuw, D. E. Horsman, J. A. Squire,
a n dW .L .L a m ,“ C y t o g e n e t i c a l l yb a l a n c e dt r a n s l o c a t i o n s
are associated with focal copy number alterations,” Human
Genetics, vol. 120, no. 6, pp. 795–805, 2007.
[140] G. Tonon, K. K. Wong, G. Maulik et al., “High-resolution
genomic proﬁles of human lung cancer,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 102, no. 27, pp. 9625–9630, 2005.
[141] C. Garnis, W. W. Lockwood, E. Vucic et al., “High resolution
analysis of non-small cell lung cancer cell lines by whole
genome tiling path array CGH,” International Journal of
Cancer, vol. 118, no. 6, pp. 1556–1564, 2006.
[142] G. Concha, G. Vogler, D. Lezcano, B. Nermell, and M.
Vahter, “Exposure to inorganic arsenic metabolites during
earlyhumandevelopment,”Toxicological Sciences,vol.44,no.
2, pp. 185–190, 1998.
[143] I. M. Kim, T. Ackerson, S. Ramakrishna et al., “The Forkhead
Box m1 transcription factor stimulates the proliferation of
tumor cells during development of lung cancer,” Cancer
Research, vol. 66, no. 4, pp. 2153–2161, 2006.